Vioxx



 


 
Lawyers for Vioxx users seek changes to pact
Friday, December 21, 2007

Reuters Health Information (2007-12-21): Lawyers for Vioxx users seek changes to pact
 
Lawyers for Vioxx users seek changes to pact
Friday, December 21, 2007

Reuters Health Information (2007-12-21): Lawyers for Vioxx users seek changes to pact
 
Vioxx plaintiffs can settle or lose lawyer: report
Friday, November 16, 2007
An unusual provision in Merck & Co Inc's settlement agreement concerning the painkiller Vioxx means...
Vioxx plaintiffs can settle or lose lawyer: report
 
Merck agrees to pay $4.85 bln in Vioxx settlement
Friday, November 09, 2007
Merck & Co has agreed to pay $4.85 billion to settle most of the claims that its painkiller Vioxx...
Merck agrees to pay $4.85 bln in Vioxx settlement
 
U.S. senator asks FDA about internal Avandia vote
Monday, October 29, 2007
A senior Republican lawmaker asked the U.S. Food and Drug Administration to confirm that an internal...
U.S. senator asks FDA about internal Avandia vote
 
Top doc urges restraint in adopting new technology
Thursday, October 04, 2007
The top heart doctor at the Cleveland Clinic, known for its innovation in cardiac medicine, has...
Top doc urges restraint in adopting new technology
 
U.S. reviews osteoporosis drugs' effect on heart
Tuesday, October 02, 2007
U.S. regulators said on Monday they were reviewing whether certain osteoporosis drugs, including...
U.S. reviews osteoporosis drugs' effect on heart
 
New York State, New York City sue Merck over Vioxx
Tuesday, September 18, 2007
The state and city of New York on Monday filed suit against Merck & Co Inc, claiming the drugmaker...
New York State, New York City sue Merck over Vioxx
 
Merck wins reversal of Vioxx class-action status
Thursday, September 06, 2007
Merck & Co Inc said on Thursday the New Jersey Supreme Court has reversed a lower court ruling that...
Merck wins reversal of Vioxx class-action status
 
Study says Vioxx danger begins earlier than stated
Thursday, July 26, 2007
The increased heart risk from Vioxx, Merck & Co's withdrawn arthritis medicine, begins much earlier...
Study says Vioxx danger begins earlier than stated
 
Less money or new trial offered in Vioxx case: WSJ
Thursday, June 07, 2007
A U.S. federal judge gave a plaintiff in a Vioxx product liability case a choice of a retrial or a...
Less money or new trial offered in Vioxx case: WSJ
 
New study adds to worries about diabetes drug class
Tuesday, May 22, 2007
Another study has found that diabetes drugs intended to help patients live longer, healthier lives...
New study adds to worries about diabetes drug class
 
Senate clears prescription drug safety bill
Wednesday, May 09, 2007
The U.S. Senate approved legislation on Wednesday to give the government new powers to police side...
Senate clears prescription drug safety bill
 
US health plans back greater scrutiny of new drugs
Thursday, April 19, 2007
U.S. health insurers, whose patient records helped uncover heart risks of the withdrawn arthritis...
US health plans back greater scrutiny of new drugs
 
Merck investors to appeal of Vioxx lawsuit ruling
Monday, April 16, 2007
Merck & Co. Inc. investors who sued over the company's disclosures about its withdrawn painkiller,...
Merck investors to appeal of Vioxx lawsuit ruling
 
U.S. panel rejects Merck's Vioxx successor
Friday, April 13, 2007
Merck & Co Inc.'s successor to the recalled pain reliever Vioxx should not be approved, a U.S....
U.S. panel rejects Merck's Vioxx successor
 
Merck urges U.S. panel to back Vioxx successor
Thursday, April 12, 2007
A pain reliever in the same family as the recalled drug Vioxx should be approved to provide an...
Merck urges U.S. panel to back Vioxx successor
 
Investors bet on Cephalon drug, but risks abound
Thursday, March 29, 2007
Cephalon Inc. is expected to win approval for a tweaked version of its sleep disorder drug Provigil...
Investors bet on Cephalon drug, but risks abound
 
Merck's Vioxx did not cause woman's death: jury
Tuesday, March 27, 2007
An Illinois jury on Tuesday found Merck & Co. Inc.'s withdrawn arthritis drug Vioxx did not cause a...
Merck's Vioxx did not cause woman's death: jury
 
NJ jury awards plaintiff $20 mln in Vioxx case
Monday, March 12, 2007
A New Jersey jury found on Monday that Merck & Co. Inc.'s withdrawn arthritis drug Vioxx was...
NJ jury awards plaintiff $20 mln in Vioxx case
 
NJ judge upholds jury's Vioxx verdict
Monday, March 05, 2007
A New Jersey judge backed a jury's verdict that Merck & Co. properly warned doctors of the safety...
NJ judge upholds jury's Vioxx verdict
 
FDA drops plan for prescription drug watch list
Monday, March 05, 2007
U.S. health officials said on Friday they had dropped plans to keep a public list of prescription...
FDA drops plan for prescription drug watch list
 
New Jersey jury splits on two Merck Vioxx cases
Friday, March 02, 2007
A New Jersey jury found on Friday that Merck & Co. failed to provide adequate warnings about health...
New Jersey jury splits on two Merck Vioxx cases
 
Rofecoxib reduces colorectal adenomas
Wednesday, January 24, 2007
The cyclo-oxygenase (COX) -2 inhibitor rofecoxib significantly reduces the risk of colorectal...
Rofecoxib reduces colorectal adenomas
 
LA judge declares mistrial in Vioxx case
Friday, January 19, 2007
A Los Angeles judge on Thursday declared mistrials in the cases of two men who blame Merck & Co.'s...
LA judge declares mistrial in Vioxx case
 
Merck faces retrial, grieving sister in Vioxx trial
Friday, January 19, 2007
Merck & Co. faces a woman who blames its withdrawn pain drug Vioxx for her brother's death and the...
Merck faces retrial, grieving sister in Vioxx trial
 
N.J. appeals court reinstates Vioxx lawsuit
Thursday, January 18, 2007
A New Jersey appeals court has revived a lawsuit that sought to force drugmaker Merck & Co. Inc. to...
N.J. appeals court reinstates Vioxx lawsuit
 
Pfizer shares at risk following heart-drug failure
Monday, December 04, 2006
With the sudden failure of torcetrapib, Pfizer Inc.'s most important experimental product, financial...
Pfizer shares at risk following heart-drug failure
 
US judge denies class status in Merck Vioxx cases
Wednesday, November 22, 2006
A federal judge on Wednesday denied a motion for class-action status for personal injury and...
US judge denies class status in Merck Vioxx cases
 
Pain drugs may raise risk of kidney failure
Friday, November 03, 2006
The use of nonsteroidal antiinflammatory drugs ("NSAID"), which include pain relievers like...
Pain drugs may raise risk of kidney failure
 
Arthritis drugs have similar risks and benefits
Tuesday, October 17, 2006
The two main types of drugs used to treat osteoarthritis offer the same pain-relief benefits and...
Arthritis drugs have similar risks and benefits
 
Vioxx risks confirmed by new studies
Tuesday, September 12, 2006
The use of Vioxx (rofecoxib), the anti-inflammatory drug at the center of many high-profile...
Vioxx risks confirmed by new studies
 
Findings confirm risks with rofecoxib use
Tuesday, September 12, 2006
Use of rofecoxib (Vioxx), the drug at the center of many high-profile lawsuits, does, in fact,...
Findings confirm risks with rofecoxib use
 
Merck wins Vioxx case in Los Angeles
Thursday, August 03, 2006
A Los Angeles jury gave Merck & Co. Inc. another court victory on Wednesday when it found the...
Merck wins Vioxx case in Los Angeles
 
Vioxx user already had heart problems, court hears
Wednesday, July 12, 2006
A lawyer for Merck & Co. told a jury on Tuesday that a 68-year-old New Jersey woman's previous...
Vioxx user already had heart problems, court hears
 
Rofecoxib but not other coxibs tied to cardiovascular risks
Friday, June 02, 2006
Alone among selective cyclo-oxygenase 2 inhibitors (coxibs) and non-steroidal anti-inflammatory...
Rofecoxib but not other coxibs tied to cardiovascular risks
 
Polemic intensifies as Merck & Co admits Vioxx study error
Wednesday, May 31, 2006
Merck & Co Inc has admitted it made a mistake in the description of how it analysed key data in a...
Polemic intensifies as Merck & Co admits Vioxx study error
 
Vioxx risk seen with short-term use
Thursday, May 18, 2006
Merck & Co. Inc. has provided new data to U.S. regulators showing that all patients who took the...
Vioxx risk seen with short-term use
 
Study shows how painkillers raise heart risk
Friday, April 14, 2006
Painkillers called COX-2 inhibitors may increase the risk of heart attacks by raising blood pressure...
Study shows how painkillers raise heart risk
 
FACTBOX -- Vioxx lawsuits against Merck
Wednesday, April 05, 2006
A jury in the latest trial against drug maker Merck & Co. Inc. is deliberating the case of two New...
FACTBOX -- Vioxx lawsuits against Merck
 
Court upholds Vioxx class action against Merck
Friday, March 31, 2006
A New Jersey appellate court on Friday upheld a judge's decision to certify a national class action...
Court upholds Vioxx class action against Merck
 
Length of time using Vioxx seen key in Merck trial
Friday, March 03, 2006
Opening arguments in the next Vioxx liability trial start on Monday as Merck & Co. faces the lone...
Length of time using Vioxx seen key in Merck trial
 
Popular heart surgery drug linked to heart attacks
Wednesday, January 25, 2006
Patients scheduled for heart surgery might want to ask their surgeon not to use a clotting drug...
Popular heart surgery drug linked to heart attacks
 
Medical journal says Merck deleted Vioxx dangers
Friday, December 09, 2005
A prestigious medical journal on Thursday said Merck & Co. withheld information about the dangers of...
Medical journal says Merck deleted Vioxx dangers
 
NEWS ALERT: On Thursday, September 30, 2004, the painkiller Vioxx (Rofecoxib) was voluntarily recalled from the marketplace by its manufacturer Merck. Vioxx has been found to double the risk of a severe cardiovascular events such as heart attacks and strokes and can even cause sudden death. Those taking higher doses of Vioxx have triple the risk of severe cardiovascular events.

The prescription painkiller Vioxx (Rofecoxib) has been recalled from the marketplace by its manufacturer Merck Pharmaceuticals. Vioxx, which is used to relieve symptoms of arthritis, acute pain in adults and painful menstrual cycles, was recalled after data collected from a clinical trial indicated that those taking Vioxx had a 100% greater chance of a severe coronary event such as a heart attack, stroke and/or sudden death. Since its introduction in 1999, upwards of 20 million Americans have taken Vioxx. It is estimated that at least 2 million Americans are currently using the drug.

The clinical trial, initially developed to determine whether Vioxx would be effective in preventing colon polyps, found that those taking the drug for longer than 18 months had double the risk of a heart attack or stroke as those taking a placebo. Those taking the highest daily recommended dosage were found to have three times the risk of a severe coronary event.

If you or a loved one have experienced any side effects from the defective drug Vioxx including heart attacks, strokes or even sudden death, please call us at 1.800.966.4999 or fill out the form to the right of the page for immediate attention to your case.



 
Schwartzapfel Partners
With over 150 years of combined experience and highly competent co-counsel throughout the country, we can serve all your legal needs. Schwartzapfel Partners protects the rights of those who aren't able to do so themselves.    Learn More



Gender: Male Female
In what state did the incident occur?

Schwartzapfel Truhowsky Marcus
       Sachs P.C. disclaimer.

Clear